Solberg S - Search Results

1

Liver transplantation for nonresectable liver metastases from colorectal cancer.

Hagness M, Foss A, Line PD, Scholz T, Jørgensen PF, Fosby B, Boberg KM, Mathisen O, Gladhaug IP, Egge TS, Solberg S, Hausken J, Dueland S. Hagness M, et al. Among authors: solberg s. Ann Surg. 2013 May;257(5):800-6. doi: 10.1097/SLA.0b013e3182823957. Ann Surg. 2013. PMID: 23360920 Clinical Trial.

2

Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases.

Dueland S, Syversveen T, Solheim JM, Solberg S, Grut H, Bjørnbeth BA, Hagness M, Line PD. Dueland S, et al. Among authors: solberg s. Ann Surg. 2020 Feb;271(2):212-218. doi: 10.1097/SLA.0000000000003404. Ann Surg. 2020. PMID: 31188200 Clinical Trial.

3

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease.

Bugge A, Lund MB, Brunborg C, Solberg S, Kongerud J. Bugge A, et al. Among authors: solberg s. Ann Thorac Surg. 2016 Jun;101(6):2125-31. doi: 10.1016/j.athoracsur.2015.12.057. Epub 2016 Mar 24. Ann Thorac Surg. 2016. PMID: 27016839

4

Cause-specific death after surgical resection for early-stage non-small-cell lung cancer.

Bugge AS, Lund MB, Valberg M, Brustugun OT, Solberg S, Kongerud J. Bugge AS, et al. Among authors: solberg s. Eur J Cardiothorac Surg. 2018 Jan 1;53(1):221-227. doi: 10.1093/ejcts/ezx274. Eur J Cardiothorac Surg. 2018. PMID: 28950311

5

Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.

Donnem T, Kilvaer TK, Andersen S, Richardsen E, Paulsen EE, Hald SM, Al-Saad S, Brustugun OT, Helland A, Lund-Iversen M, Solberg S, Gronberg BH, Wahl SG, Helgeland L, Fløtten O, Pohl M, Al-Shibli K, Sandanger TM, Pezzella F, Busund LT, Bremnes RM. Donnem T, et al. Among authors: solberg s. Ann Oncol. 2016 Feb;27(2):225-32. doi: 10.1093/annonc/mdv560. Epub 2015 Nov 16. Ann Oncol. 2016. PMID: 26578726 Free article. Review.

6

Incidence and survival of malignant pleural mesothelioma in norway: a population-based study of 1686 cases.

Helland Å, Solberg S, Brustugun OT. Helland Å, et al. Among authors: solberg s. J Thorac Oncol. 2012 Dec;7(12):1858-1861. doi: 10.1097/JTO.0b013e318275b346. J Thorac Oncol. 2012. PMID: 23154557 Free article.

7

Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016.

Brustugun OT, Grønberg BH, Fjellbirkeland L, Helbekkmo N, Aanerud M, Grimsrud TK, Helland Å, Møller B, Nilssen Y, Strand TE, Solberg SK. Brustugun OT, et al. Lung Cancer. 2018 Aug;122:138-145. doi: 10.1016/j.lungcan.2018.06.003. Epub 2018 Jun 6. Lung Cancer. 2018. PMID: 30032822

8

Osteopontin is a prognostic biomarker in non-small cell lung cancer.

Rud AK, Boye K, Oijordsbakken M, Lund-Iversen M, Halvorsen AR, Solberg SK, Berge G, Helland A, Brustugun OT, Mælandsmo GM. Rud AK, et al. BMC Cancer. 2013 Nov 11;13:540. doi: 10.1186/1471-2407-13-540. BMC Cancer. 2013. PMID: 24215488 Free PMC article.

9

Gender-specific survival after surgical resection for early stage non-small cell lung cancer.

Bugge A, Kongerud J, Brunborg C, Solberg S, Lund MB. Bugge A, et al. Among authors: solberg s. Acta Oncol. 2017 Mar;56(3):448-454. doi: 10.1080/0284186X.2016.1253862. Epub 2016 Nov 16. Acta Oncol. 2017. PMID: 27846762

10

Increase in curative treatment and survival of lung cancer in Norway 2001-2016.

Solberg S, Nilssen Y, Brustugun OT, Grimsrud TK, Haram PM, Helbekkmo N, Helland Å, Hjelde HH, Jakobsen B, Møller B, Petersen M, Strand TE, Wahl SGF, Aanerud M, Fjellbirkeland L. Solberg S, et al. Eur J Epidemiol. 2019 Oct;34(10):951-955. doi: 10.1007/s10654-019-00536-z. Epub 2019 Jul 16. Eur J Epidemiol. 2019. PMID: 31313073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page